Arcturus Therapeutics : Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan
Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan Meiji Holdings Co., Ltd. Announces that...
Source: marketscreener.com